Skip to main content
Fig. 10 | Stem Cell Research & Therapy

Fig. 10

From: A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6

Fig. 10

The proportion of Th2 cells and Th17 cells in MLN after treatment with TSG-6 siRNA knockdown MSCs-Exo (siTSG-6 Exo). Flow cytometry plots and graph analysis of Th2 cells (a) and Th17 cells (b) in the MLN from the DSS + PBS, DSS + siNC Exo and DSS + siTSG-6 Exo groups. Data are presented as mean ± SD; n = 4 per group. *P < 0.05 and ns indicates P > 0.05

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512